Covered recipient · General Payments record
LAURA L ENGBRETSON
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$2,956.92
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $557.31 | 24 |
| Education | $40.05 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $156.85 | 6 |
| PFIZER INC. | $99.14 | 5 |
| Novo Nordisk AS | $85.19 | 4 |
| Astellas Pharma US Inc | $63.86 | 2 |
| Pacira Pharmaceuticals Incorporated | $47.38 | 2 |
| SHIELD THERAPEUTICS INC | $46.36 | 2 |
| MILLICENT US INC | $40.05 | 1 |
| Sumitomo Pharma America, Inc. | $24.52 | 1 |
| CooperSurgical, Inc. | $17.25 | 1 |
| DAVOL INC. | $16.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $33.32 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139360365 | CMS |
| Astellas Pharma US Inc | $30.54 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139406443 | CMS |
| Biogen, Inc. | $27.30 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104861838 | CMS |
| Biogen, Inc. | $25.79 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104812593 | CMS |
| Biogen, Inc. | $26.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104814765 | CMS |
| Biogen, Inc. | $22.37 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104858260 | CMS |
| Biogen, Inc. | $28.75 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104807029 | CMS |
| Biogen, Inc. | $26.54 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104877850 | CMS |
| CooperSurgical, Inc. | $17.25 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150801688 | CMS |
| Davol Inc. | $16.76 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127666016 | CMS |
| MILLICENT US INC | $40.05 | 10/22/2024 | Education | Undisputed | 01/23/2026 | 1150906666 | CMS |
| Novo Nordisk Inc | $20.22 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096963394 | CMS |
| Novo Nordisk Inc | $23.19 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097505330 | CMS |
| Novo Nordisk Inc | $23.04 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097479710 | CMS |
| Novo Nordisk Inc | $18.74 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097023764 | CMS |
| Pacira Pharmaceuticals Incorporated | $23.14 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151251842 | CMS |
| Pacira Pharmaceuticals Incorporated | $24.24 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151251840 | CMS |
| PFIZER INC. | $15.44 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131164563 | CMS |
| PFIZER INC. | $21.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131308371 | CMS |
| PFIZER INC. | $21.69 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131630614 | CMS |
| PFIZER INC. | $17.89 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132025009 | CMS |
| PFIZER INC. | $23.12 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131630618 | CMS |
| SHIELD THERAPEUTICS INC | $25.50 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150149604 | CMS |
| SHIELD THERAPEUTICS INC | $20.86 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150153672 | CMS |
| Sumitomo Pharma America, Inc. | $24.52 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148848879 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.